Atrial Fibrillation

Atrial fibrillation is a mysterious disease. We know a lot but surely not enough. We look at AF but are we really seeing it? I believe there are hard truths to this disease. Hard in a way that neither patients nor doctors like - John Mandrola MD

Atrial Fibrillation

image by: StopAfib
     

HWN Recommends

The A-Fib Marketing Blitz: Be Still My Heart


With breathtaking speed, atrial fibrillation has gone from “Huh?” to parlance. “A-fib”, a common cardiac cause of palpitations, is now in the front ranks of evils lurking to smite our well-being. There is no mystery to this transformation. In 2013, the Food and Drug Administration licensed three new drugs to prevent a stroke, the fearful complication of A-fib: apixaban (Eliquis), rivaroxaban (Xarelto) and dibatigatran (Pradaxa). This unleashed the full might of pharmaceutical marketing: the scientific data for efficacy that convinced the FDA is tortured till it convinced “thought leaders” whose opinions convinced influential journalists. Sales pitches populate print, broadcast and social…

read full article

Resources

Related Articles

Stroke - Is the Treatment Worth the Risk?

Stroke - Is the Treatment Worth the Risk?

It's sad to say that customary stroke treatment is similar to how heart attacks were treated before the 1970's. New technology is needed, not just clot busters. In the meantime know where the nearest stroke treatment center is

Stroke - Can We Turn It Around?

The Stroke Epidemic Part One - Can We Turn It Around?

Not only is stroke incidence increasing but there is usually no effective treatment. In the meantime controlling the risk factors of high blood pressure, diabetes and weight may help decrease your risk

Stroke - Is the Treatment Worth the Risk?

Stroke - Is the Treatment Worth the Risk?

It's sad to say that customary stroke treatment is similar to how heart attacks were treated before the 1970's. New technology is needed, not just clot busters. In the meantime know where the nearest stroke treatment center is

Stroke - Can We Turn It Around?

The Stroke Epidemic Part One - Can We Turn It Around?

Not only is stroke incidence increasing but there is usually no effective treatment. In the meantime controlling the risk factors of high blood pressure, diabetes and weight may help decrease your risk

Stroke - Is the Treatment Worth the Risk?

Stroke - Is the Treatment Worth the Risk?

It's sad to say that customary stroke treatment is similar to how heart attacks were treated before the 1970's. New technology is needed, not just clot busters. In the meantime know where the nearest stroke treatment center is

Stroke - Can We Turn It Around?

The Stroke Epidemic Part One - Can We Turn It Around?

Not only is stroke incidence increasing but there is usually no effective treatment. In the meantime controlling the risk factors of high blood pressure, diabetes and weight may help decrease your risk

Stay Connected

©2021 | HealthWorldNet, Inc. | 2490

Last Updated : Friday, January 22, 2021